← Leaderboards
Alexander V Birk
Weill Medical College Of Cornell Univ
$537,188
Attributed
$537,188
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $111K · FY2005–08$200K$150K$100K$50K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$537,188 · 2
By mechanism
K01$534,642 · 1
F31$2,546 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- Peter W Schiller$3,886,349
- Samie R Jaffrey$42,543,108
- Hazel H Szeto$8,842,007
- Julianne L Imperato-McGinley$179,286,606
Others in their field
Top investigators on “Analog”
- David Heimbrook · Leidos Biomedical Research, Inc.$196,589,777
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Norman Wolmark · Nsabp Foundation, Inc.$51,982,954
- Robert Turner Schooley · University Of Colorado Denver$48,513,949
- Kenneth A Bloom · University Of Nebraska-Lincoln$46,979,168
- John Hobbs · Suny At Stony Brook$41,239,084
Research focus
AnalogRnase Protection AssayGenetic TranslationHepatitis C VirusArginineHepatitis CLysineTissue /Cell CultureSynthetic PeptideCapping Of MrnaAdverse EffectsBlotting, WesternEndoribonucleasesCell Free SystemBlotting, NorthernDigestionDrug Design /Synthesis /ProductionClinical ApplicationBiochemistry And Pharmacology Cancer ActivityAnti-Hepatitis CCytotoxicDesignChronicBinding (Molecular Function)
Grant awards (7)
SELECTIVE INHIBITION OF HCV TRANSLATION BY TETRAPEPTIDE$111,000
K01 · FY2008 · DA · contact PI
SELECTIVE INHIBITION OF HCV TRANSLATION BY TETRAPEPTIDE$108,000
K01 · FY2007 · DA · contact PI
SELECTIVE INHIBITION OF HCV TRANSLATION BY TETRAPEPTIDE$54,216
K01 · FY2006 · DA · contact PI
SELECTIVE INHIBITION OF HCV TRANSLATION BY TETRAPEPTIDE$50,998
K01 · FY2006 · DA · contact PI
SELECTIVE INHIBITION OF HCV TRANSLATION BY TETRAPEPTIDE$105,214
K01 · FY2005 · DA
SELECTIVE INHIBITION OF HCV TRANSLATION BY TETRAPEPTIDE$105,214
K01 · FY2004 · DA
INHIBITION OF DYNORPHIN STIMULATED ACTH RELEASE$2,546
F31 · FY2000 · DA